Literature DB >> 23622975

Location, location, location: does early cancer in Barrett's esophagus have a preference?

Brintha K Enestvedt1, Ricardo Lugo, Carlos Guarner-Argente, Pari Shah, Gary W Falk, Emma Furth, Gregory G Ginsberg.   

Abstract

BACKGROUND: Early cancer (high-grade dysplasia [HGD] and intramucosal carcinoma [ImCa]) associated with Barrett's esophagus (BE) may have a circumferential spatial predilection.
OBJECTIVE: To describe the esophageal circumferential location of early cancer in BE. DESIGN AND
SETTING: Retrospective study, single tertiary referral center. PATIENTS AND INTERVENTION: One hundred nineteen patients were referred for endoscopic eradication therapy for early cancer associated with BE. Endoscopic images and reports and pathology were reviewed. MAIN OUTCOME MEASUREMENTS: Circumferential location designation of early cancer in BE by using a clock-face orientation.
RESULTS: One hundred nineteen of 131 patients referred for endoscopic eradication therapy had a location designation for their advanced histology (91.9%). There were a total of 57 patients (47.9%) with HGD and 62 patients (52.1%) with ImCa. There was a significantly higher rate of early cancer (HGD or ImCa) in the right hemisphere (12 to 6 o'clock location) compared with the left hemisphere (84.9% vs 15.1%, P < .0001). The highest percentage of early cancer was found in the 12 to 3 o'clock quadrant (64.7%); 71.9% of HGD and 58.1% of ImCa lesions were located in the 12 to 3 o'clock quadrant. LIMITATIONS: Retrospective design, single center.
CONCLUSIONS: Early cancer associated with BE is far more commonly found in the right hemisphere of the esophagus (12 to 6 o'clock) with the highest rate in the 12 to 3 o'clock quadrant. These findings support enhanced scrutiny of the right hemisphere of the esophagus during surveillance and endoscopic treatment of patients with BE.
Copyright © 2013 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  BE; Barrett’s esophagus; HGD; ImCa; high-grade dysplasia; intramucosal carcinoma

Mesh:

Year:  2013        PMID: 23622975     DOI: 10.1016/j.gie.2013.03.167

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  22 in total

Review 1.  Endoscopic options for early stage esophageal cancer.

Authors:  Pari M Shah; Hans Gerdes
Journal:  J Gastrointest Oncol       Date:  2015-02

Review 2.  Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus.

Authors:  Magnus Halland; David Katzka; Prasad G Iyer
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 3.  Barrett's esophagus: diagnosis and management.

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2017-01-18       Impact factor: 9.427

Review 4.  Barrett's oesophagus: frequency and prediction of dysplasia and cancer.

Authors:  Gary W Falk
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-01-20       Impact factor: 3.043

5.  Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location.

Authors:  Cary C Cotton; W Asher Wolf; Sarina Pasricha; Nan Li; Ryan D Madanick; Melissa B Spacek; Kathleen Ferrell; Evan S Dellon; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2015-03-24       Impact factor: 9.427

Review 6.  How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?

Authors:  Venkata Subhash Gorrepati; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

Review 7.  Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.

Authors:  Matthew J Whitson; Gary W Falk
Journal:  Gastroenterol Clin North Am       Date:  2015-03-31       Impact factor: 3.806

8.  Localization of specialized intestinal metaplasia and the molecular alterations in Barrett esophagus in a Japanese population: an analysis of biopsy samples based on the "Seattle" biopsy protocol.

Authors:  Shota Fukui; Jiro Watari; Toshihiko Tomita; Takahisa Yamasaki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Hisatomo Ikehara; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Kiron M Das; Hiroto Miwa
Journal:  Hum Pathol       Date:  2016-01-07       Impact factor: 3.466

Review 9.  Optimizing early upper gastrointestinal cancer detection at endoscopy.

Authors:  Andrew M Veitch; Noriya Uedo; Kenshi Yao; James E East
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-11       Impact factor: 46.802

10.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.